Skip to content

Microcurrent Stimulation to Treat Macular Degeneration

An Observational, Multi-Center Phase 1 Study of the Safety and Effectiveness of Frequency Specific Microcurrent Stimulation as an Alternative Treatment for Retinal Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01790958
Enrollment
50
Registered
2013-02-13
Start date
2012-06-30
Completion date
2012-12-31
Last updated
2013-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Diseases, Retinitis Pigmentosa, Stargardt's Disease

Brief summary

Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.

Detailed description

This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.

Interventions

None listed

Sponsors

Retina Institute of Hawaii
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ability to provide written consent and comply with follow up visits * Age 40 years or older * ETDRS best corrected visual acuity better than 5 letters * History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease * No Anti-VEGF treatments for at least 3 months prior to study * No new antioxidant/vitamin supplementation for at least 3 months prior to study

Exclusion criteria

* History of Non-Compliance with regular medical visits * Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity * Presence of pigment epithelial tears or rips * Known serious allergies to fluorescein dye * Presence of retinal neovascularization * Any treatment with an investigation agent in the past 30 days

Design outcomes

Primary

MeasureTime frame
Measure visual acuity after receiving microcurrent stimulation treatments.6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026